Refractory metabolic acidosis as a complication of high-dose midazolam infusion for pediatric status epilepticus

Clinical Neuropharmacology

Volumn 32, Issue 6, 2009, Pages 340-341

  Federman, Myke D ^a   Kelly, Robert ^a   Harrison, Rick E ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Epilepsy; Metabolic acidosis; Midazolam; Status epilepticus

Indexed keywords

MIDAZOLAM;

ARTICLE; CASE REPORT; CHILD; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG FORMULATION; DRUG INFUSION; DRUG MEGADOSE; DRUG TOLERABILITY; EPILEPTIC STATE; FEMALE; HEMODYNAMICS; HUMAN; HYPERCHLOREMIA; METABOLIC ACIDOSIS; PRIORITY JOURNAL; SCHOOL CHILD;

ACIDOSIS; ANTICONVULSANTS; CARDIOTONIC AGENTS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MIDAZOLAM; STATUS EPILEPTICUS; VASOPRESSINS;

EID: 74249104867     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181b77d07     Document Type: Article

References (16)

1. Hauser WA. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994;35:S1-S6.
2. Raspall-Chaure M, Chin RFM, Neville BG, et al. The epidemiology of convulsive status epilepticus in children: a critical review. Epilepsia 2007;48:1652-1663.
3. Rivera R, Segnini M, Baltonado A, et al. Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993;21:991-994.
4. Parent JM, Lowenstein DH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994; 44:1837-1840.
5. Koul RL, Aithala GR, Chacko A, et al. Continuous midazolam infusion as treatment of status epilepticus. Arch Dis Child 1997;76:445-448.
6. Igartua J, Peter S, Maytal J, et al. Midazolam coma for refractory status epilepticus in children. Crit Care Med 1999;27:1982-1985.
7. Ulvi H, Yoldas T, Mungen B, et al. Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus. Neurol Sci 2002;23:177-182.
8. Ozdemir D, Gulez P, Uran N, et al. Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus. Seizure 2005;14:129-132.
9. Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med 2006;32:2070-2076.
10. Hayashi K, Osawa M, Aihara M. Efficacy of intravenous midazolam for status epilepticus in childhood. Pediatr Neurol 2007;36:366-372. (Pubitemid 46873924)
11. Gilbert DL, Gartside PS, Glauser TA. Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a meta-analysis. J Child Neurol 1999;14:602-609.
12. Wilson KC, Reardon C, Theodore AC, et al. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest 2005;128:1674-1681.
13. Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med 1997;15:357-365.
14. Brown WJ, Buist NRM, Gipson HTC, et al. Fatal benzyl alcohol poisoning in a neonatal intensive care unit. Lancet 1982;1:1250.
15. Pepperman ML, Macrae D. A comparison of propofol and other sedative use in paediatric intensive care in the United Kingdom. Paediatr Anaesth 1997;7:143-153.
16. Naritoku DK, Sinha S. Prolongation of the midazolam half-life after sustained infusion for status epilepticus. Neurology 2000;54(6): 1366-1368.